利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

50 条记录 (耗时 0.012 秒)

    HERBAL POLYPHARMACEUTICAL FOR PREVENTING AND TREATING ATHEROSCLEROSIS
    23.
    发明公开
    HERBAL POLYPHARMACEUTICAL FOR PREVENTING AND TREATING ATHEROSCLEROSIS 有权
    草本药物用于预防和治疗动脉粥样硬化

    公开(公告)号：EP2684567A1

    公开(公告)日：2014-01-15

    申请号：EP12758054.6

    申请日：2012-03-09

    申请人： Castañeda Miranda, José Arturo

    发明人： Castañeda Miranda, José Arturo

    IPC分类号： A61K36/515 ,  A61K36/37 ,  A61P9/10

    CPC分类号： A61K36/515 ,  A61K36/37 ,  A61K2300/00

    摘要： Herbal MDR for the prevention and treatment of atherosclerosis which includes a summary of the genus Gentiana and a summary of the genus Hippocratea, in particular, gentiana lutea and hippocratea excelsa. Comes as a solid, preferably capsules. Herbal composition is obtained by selecting Rhizome and root of Gentiana luteablending by centrifugation, and separating the supernatant which mingles with the alcoholic extract of Hippocratea excelsa. Applies in the prevention and treatment of atherosclerosis, as well as in atherosclerotic Occlusive disease complications such as blockage of coronary arteries and arteries that supply the heart.

    摘要翻译： 用于预防和治疗动脉粥样硬化的草药MDR，其包括Gentiana属的总结和Hippocratea属的总结，特别是黄体酮和hippocratea excelsa。 来自固体，最好是胶囊。 草药组合物是通过离心选择龙胆根和黄芩根，然后分离与希波克拉霉素酒精提取物混合的上清液。 适用于动脉粥样硬化的预防和治疗，以及动脉粥样硬化闭塞性疾病并发症，如阻塞供应心脏的冠状动脉和动脉。

    Compositions for delaying progression of diabetes using Salacia oblonga extract
    24.
    发明公开
    Compositions for delaying progression of diabetes using Salacia oblonga extract 审中-公开
    使用的组合物长圆五层龙提取物 - 延缓糖尿病的发展

    公开(公告)号：EP2397039A1

    公开(公告)日：2011-12-21

    申请号：EP10380083.5

    申请日：2010-06-21

    申请人： Abbott Laboratories

    发明人： Rueda Cabrera, Ricardo ,  Manzano Martin, Manuel ,  Lopez Pedrosa, Jose Maria

    IPC分类号： A23L1/30 ,  A61K36/37

    CPC分类号： A61K36/37 ,  A23L33/105 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/328 ,  A23V2250/21

    摘要： Disclosed are nutritional compositions and methods for delaying the onset or progression of type 2 diabetes in a subject. The methods include administering to a glucose intolerant or diabetic subject a nutritional composition comprising an effective amount of a Salacia oblonga extract for increasing the incretin effect (and/or the glucagon-like peptide-1 and/or gastric inhibitory peptide activity) in the subject. The Salacia oblonga extract may also act to reduce the secretion of glucagon by the pancreas thus decreasing the glucose level in the bloodstream of the subject.

    摘要翻译： 本发明公开了营养组合物和用于延迟2型糖尿病的发作或进展中的受试者的方法。 该方法包括施用给葡萄糖不耐症或糖尿病受试者的营养组合物用于增加肠降血糖素效应包括有效量的长圆五层龙提取物（和/或胰高血糖素样肽-1和/或抑胃肽活性）在受试者 ， 因此，该长圆五层龙提取物可以充当由从而减少受试者的血流中的葡萄糖水平胰腺胰高血糖素减少的分泌。